Masimo CORP 8-K filings

Masimo appoints an interim CEO, Michelle Brennan, following the resignation of Joe Kiani, while reaffirming its financial guidance for the third quarter of 2024 and continuing its strategic review of consumer businesses.

Masimo is actively exploring strategic options for its consumer business, including a potential joint venture, spin-off, or sale, while focusing on maximizing shareholder value.

Masimo Corporation announced strong second-quarter 2024 financial results, driven by record contracting efforts and margin expansion, leading to an increased full-year 2024 guidance.

Masimo Corporation has postponed its 2024 Annual Meeting of Stockholders to September 19, 2024, and initiated litigation against Politan Capital Management LP for alleged misstatements in proxy materials.

Masimo reports a 9% consolidated revenue growth, driven by a 22% surge in healthcare revenue, while non-healthcare revenue declined by 13% in preliminary Q2 2024 results.

Masimo is in discussions to sell a majority stake in its consumer business for a potential price between $850 million and $950 million, while also considering a spin-off.

Masimo's Chief Operating Officer, Bilal Muhsin, has stated his intention to resign if Politan Capital takes control of the company.

Masimo is evaluating a potential separation of its consumer business to maximize shareholder value and focus on its professional healthcare segment.

Masimo corrects previously stated recall numbers for its Rad-G devices, specifying 7,350 units in the U.S. and 20,250 units outside the U.S., while continuing to cooperate with the Department of Justice investigation.

Masimo Corporation reports the resignation of Rolf Classon from the Board and Audit Committee due to personal health reasons, and the appointment of Robert Chapek to the Audit Committee.

Masimo's first quarter results show a mixed performance with healthcare revenue at the high end of guidance, while the company plans to separate its consumer business.

Masimo's Board of Directors has authorized management to explore a potential separation of its consumer business, including audio and health products, from its professional healthcare division.

Masimo Corporation announced its fourth quarter and full-year 2023 financial results, showing a mix of revenue performance and providing updated financial guidance for 2024.

Masimo Corporation reports the resignation of board member Adam Mikkelson for personal reasons, effective February 29, 2024, and announces subsequent committee appointments.

Masimo Corporation has appointed Robert A. Chapek, former CEO of The Walt Disney Company, to its Board of Directors, effective January 15, 2024.